Percutaneous System For Creating AVF For Hemodialysis
TVA Medical, Inc. has developed a catheter-based system for the creation of an arteriovenous fistula in patients requiring hemodialysis. For millions of patients worldwide receiving hemodialysis therapy, TVA Medical intends to transform the open surgical procedure into a minimally invasive procedure by using a catheter-based approach.
The everlinQ™ endoAVF System is not available for sale in the United States and is pending FDA clearance. The Device has been issued European CE Mark and Health Canada Medical Device License for the creation of an arteriovenous fistula in patients with chronic kidney disease requiring hemodialysis.